Company: KROS
Filing Date: 2025-08-06
Form Type: 8-K
Source: 0001664710-25-000071
Chunk: 8

Company: Keros Therapeutics, Inc.
Filing Date: 2025-08-06
Form: 8-K
Item: Item 9.01
Chunk 8
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit                                                                                                                                     
      No.      Description                                                                                                                    
     99.1      Corporate Presentation dated August 2025.                                                                                      
     99.2      Press Release dated August 6, 2025.                                                                                            
     10.1      Employment Agreement by and between Keros Therapeutics, Inc. and Lorena Lerner, dated as of August 6, 2025.                    
     10.2      Separation and Release Agreement by and between Keros Therapeutics, Inc. and Christopher Rovaldi, dated as of August 6, 2025.  
     10.3      Employment Agreement by and between Keros Therapeutics, Inc. and Esther Cho, dated as of August 6, 2025.                       
      104      Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)                       

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  KEROS THERAPEUTICS, INC.                               
  By:                           /s/ Jasbir Seehra        
                                Jasbir Seehra, Ph. D.    

Dated: August 6, 2025